Thioredoxin overexpression in HT-1080 cells induced cellular senescence and sensitization to gamma radiation  by Byun, Hee Sun et al.
FEBS 29730 FEBS Letters 579 (2005) 4055–4062Thioredoxin overexpression in HT-1080 cells induced cellular
senescence and sensitization to gamma radiation
Hee Sun Byuna, Eun Wie Chob, Jin Sik Kima, Myung Sook Moona, Jung Joo Yumc,
Kug Chan Kima, In Gyu Kima,*
a Department of Radiation Biology, Environmental Radiation Research Group, Korea Atomic Energy Research Institute, P.O. Box 105,
Yuseong, Daejeon 305-600, Republic of Korea
b Systemic Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology, P.O. Box 115, Yuseong,
Daejeon 305-333, Republic of Korea
c Department of Biology, Chongju University, Chongju 360-764, Republic of Korea
Received 1 April 2005; revised 7 June 2005; accepted 14 June 2005
Available online 6 July 2005
Edited by Varda RotterAbstract An increment of thioredoxin-1 (TRX) is observed in
many human primary cancers and appears to contribute to an in-
crease of cell growth and a resistance to chemotherapy. On the
contrary, when TRX was overexpressed in the HT-1080 ﬁbrosar-
coma cells, the cell growth was retarded and chromosomal
polyploidy and cellular senescence were induced. TRX-overex-
pression made HT-1080 cells resistant to an oxidative stress
caused by H2O2 or paraquat. But these cells were signiﬁcantly
sensitive to ionizing radiation, showing an abrogation of the G2
checkpoint. Their DNA contents were twice of the controls
and they expressed typical senescence markers. Their expression
levels of p53 and cyclin-dependent kinase inhibitors (CDKI) were
about 2–3-fold higher than the control. Nevertheless, cyclin D1
and D3, which are negatively regulated by CDKIs, were also
increased. Overall, in HT-1080 cells the TRX-overexpression
created a state of cellular senescence caused by a simultaneous
stimulation of the mitogen-activated pathways and an inhibition
of the cyclin-dependent kinases, which is known as a hypermito-
genic arrest.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cyclin D1; HT-10801. Introduction
Reactive oxygen species (ROS) actively participate in a di-
verse array of biological processes, including normal cell
growth, induction and maintenance of the transformed state,
apoptosis and cellular senescence [1]. Thioredoxin-1 (TRX-1)
is a cellular redox enzyme that plays multiple roles in these re-
dox-dependent cellular events [2]. TRX-1 regulates the func-
tional states of many transcription factors, such as the
nuclear factor-jB and hypoxia-inducing factor 1-a. TRX-1
also regulates the activity of some of the kinases, which are
important in a signaling pathway such as an apoptosis sig-
nal-regulating kinase 1 and protein kinase C a, d, e, and h. An-
other important aspect of TRX-1 is that it acts as a potent*Corresponding author. Fax: +82 42 861 9560.
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doi:10.1016/j.febslet.2005.06.023cell growth and survival factor. Mouse WEHI7.2 lymphoma
cells transfected with human TRX-1 form tumors in immuno-
deﬁcient acid mice that grow more rapidly and show less
spontaneous and drug-induced apoptosis [3]. And the TRX-
overexpression has been reported in several human primary
cancers, including lung, colon, cervix and it has been linked
to aggressive tumor growth and inhibition of the apoptotic cell
death [4].
Ionizing radiation has been known to cause apoptosis via
oxidative stress in part [5]. We have studied on the role of
the TRX-1 system against various stresses including an ioniz-
ing radiation using TRX-1-overexpressed ﬁbrosarcoma HT-
1080 cells. The overexpression of TRX-1 in the HT-1080 cells
enhanced the ROS-scavenging activity, but the radiation-
induced apoptotic cell death was much higher than in the
control cells. And the overexpression of TRX-1 induced the
polyploidy and the cellular senescence as well as the cell
growth inhibition. So, we analyzed and discussed about these
phenomena.2. Materials and Methods
2.1. Cell culture and transfection
Human ﬁbrosarcoma HT-1080 cells were obtained from the Ameri-
can type Culture cellection (Manassas, VA) and the cells were cultured
in Dulbeccos modiﬁed Eagles medium (Life Technologicals Inc.,
USA) supplemented with 2 mM glutamine, 10% (v/v) fetal bovine ser-
um (JRH biosciences, USA), 100 U/ml of penicillin, and 100 lg/ml of
streptomycin (Sigma, USA), at 37 C in a 5% CO2 humidiﬁed incuba-
tor. The HT-1080 cells were transfected with pcDNA-TRX-1 vector or
an empty vector using Lipofectamine 2000 (Life Technologicals Inc.,
USA). Stably transfected cells were selected with a G418 treatment
(500 lg/ml). The medium was replaced with fresh G418-supplement
on every 3 days. The cDNA of the human TRX-1 was kindly provided
by Dr. Yodoi (University of Kyoto, Japan) and cloned into the
pcDNA3.1 vector (Invitrogen Co., USA).
2.2. Chemical treatments and c irradiation
TRX-1 transfected and control HT-1080 cells were plated in the
T25 ﬂask (5 · 105 cells/ﬂask) and after 18 h they were treated with
chemicals or irradiated. H2O2 was treated to a ﬁnal concentration
of 100 lM for 4 h and then the media were replaced with a fresh
one and the cells were cultured for another 24 h. Paraquat was trea-
ted to a ﬁnal concentration of 1 mM and c-irradiation was done at a
single does of 10 or 20 Gy (dose rate: 2 Gy/min). Then, the cells were
cultured in a 5% CO2 humidiﬁed incubator during the indicated time
period.blished by Elsevier B.V. All rights reserved.
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Control and TRX-1-transfected HT-1080 cells were seeded in a
six-well plate (1 · 105 cells/well) and cultured for 3 days. At day 1,
2, and 3, the viable cells were counted by the trypan blue dye exclu-
sion method. Apoptotic cell death was determined by the propidium
iodide staining and the ﬂow cytometric analysis as described before
[6].
2.4. Chromosome analysis
For the preparation of the metaphase cells, 0.2 lg/ml of colchicine
(Sigma, USA) was added to each cell culture for 5 h. And the cells were
trypsinized, treated with hypotonic solution (75 mM KCl) for 10 min
and ﬁxed in the methanol/glacial acetic acid solution (3:1 (v/v)). The
ﬁxed cells were dropped onto clean glass slides. Following an air
dry, the chromosomes were stained with Giemsa solution and analyzed
with the microscope.2.5. Flow cytometic and ﬂuorescence microscopic analysis of the
intracellular stained cells
Suspensions of HT-1080 cells (5 · 105cells) were ﬁxed with a
BDcytoﬁx/cytoperm solution (BD Biosciences, USA) for 20 min at
4C. Thereafter, they were washed with a BDperm/wash solution
and incubated with 0.5 lg/ml mouse anti-human thioredoxin IgG-
FITC (BD Biosciences, USA) or anti-p53 IgG-FITC (BD Biosci-
ences, USA) for 30 min at 4 C. After the washing, the cells were
analyzed using a FACScan (Coulter Co. Epix, USA) equipped with
a single 488-nm argon laser. When analyzing them with ﬂuorescence
microscopy (Leica, Germany), cells attached on coverslips were ﬁxed
and stained as described above. Anti-tubulin antibody (Santa Cruz
biotechnology, USA), anti-actin antibody (Sigma, USA) and the
corresponding secondary antibodies were used for the cytoskeleton
protein detection.Fig. 1. Apoptotic cell death of TRX-1-overexpressed HT-1080 cells after th
cells and control cells (A) were treated with 100 lM H2O2 (B) or 1 mM para
apoptotic cell deaths were measured by propidium iodide staining. Non-trans
(Mock) cells were indicated.2.6. Western blot analysis
Cell lysates were prepared in TBS containing 1% NP-40 and equal
amounts of protein (10 or 20 lg/well) were separated on a 12.5%
SDS–polyacrylamide gel. The proteins were transferred onto nitrocel-
lulose membranes and revealed by using primary antibodies (mouse
anti-human TRX Ab: BD biosciences, USA; anti-p53 Ab, anti-cyclin
D1, D3, p21, p27 Ab: Cell Signaling Technology, USA; anti-SM22
(transgelin) Ab: ABcam, UK), the corresponding secondary antibody
(anti-mouse or rabbit IgG antibody conjugated with HRP: Cell Signal-
ing Technology, USA), and an ECL detection kit (Amersham, UK).
Protein concentrations were determined by the Lowry method [7]
and for the protein concentration normalization for equal loading,
each blot was probed with anti-glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) antibody (Stressgen Bioreagents, Canada). Intensity
of each ECL-detected band was quantiﬁed using GEL-DOC software
(Biorad) and the relative amount of each band compared to that of
wild-type control sample was indicated.
2.7. Preparation of the cDNA probe and microarray hybridization
The cDNA microarray containing a set of 8096 human cDNA was
provided by GenomicTree, Inc (South Korea). Total RNA was puri-
ﬁed by using a RNA puriﬁcation kit (Qiagen, Germany) and the syn-
thesis of the target cDNA probes and hybridization were performed
according to a previously described procedure [8].
2.8. Senescence associated b-galactosidase (SA-b-Gal) activity staining
Cells (2 · 105/ml) were harvested and washed twice with 3 ml of PBS
and ﬁxed in 2% formaldehyde–0.25% glutaraldehyde. Then the cells
were washed with PBS and incubated overnight at 37 C with a freshly
prepared b-Gal staining solution (1 mg of 5-bromo-4-chloro-3-indolyl-
b-D-galactopyranoside (X-gal) per ml of 40 mM citric acid–phosphate
buﬀer (pH 6.0) containing 5 mM potassium ferrocyanide, 5 mM potas-
sium ferricyanide, 2 mM MgCl2 and 150 mM NaCl). The stained cells
were observed with optical microscope (Leica, Germany).e oxidant-treatments or c-irradiation. TRX-1-overexpressed HT-1080
quat (C) or c-irradiated at 20 Gy (D) as described in Section 2 and the
fected (WT), TRX-overexpressed (TRX), and empty-vector transfected
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3.1. TRX-1-overexpressed HT-1080 cells were resistant to
oxidants, but sensitive to c-irradiation
To conﬁrm the overexpression of functional TRX-1, TRX-1-
overexpressed HT1080 cells (TRX-HT1080) (Fig. 1A) were
treated with H2O2 or paraquat and the apoptotic cell death
was measured. As shown in Fig. 1B, the exposure to H2O2 in-
duced apoptotic cell death by 27–30% of the control cells, but
the TRX-HT1080 cells endured the oxidative stress and their
apoptotic cell death was only up to 5% less or nothing at all.
Antioxidant response of TRX-HT1080 cells was same for an-
other oxidative stress generator, paraquat. Paraquat is known
to generate intracellular ROS, especially superoxide anion [9].
96 h after the treatment of paraquat, the apoptotic cell death
was up to 60% of the control cells, but in the case of the
TRX-HT1080 cells, the cell death was about half of that
(Fig. 1C). Ionizing radiation has been known to cause apopto-
sis via oxidative stress in part. Scavenging ROS by an overex-Fig. 2. The cell phase transition of c-irradiated TRX-1-overexpressed cells. (A
by ﬂow cytometry. (B) The c-irradiated control cells showed G2 phase transit
was abrogated.pression of Mn-SOD, glutathione peroxidase or by anti-
oxidants prevented the cell death triggered by an c-irradiation
[5]. But the antioxidant function of the TRX-1 in TRX-1080
cells could not protect the c-radiation-induced cell death.
TRX-HT1080 cells showed a higher cell death than the control
about twofold (Fig. 1D).
An c-irradiation on the normal cells induces a sequential cell
phase transition into the G2 phase (G1/G0ﬁ Sﬁ G2/M
phase), which has been shown to be important in protecting
the cells from death [10]. And a severe G1 phase-arrest or an
abrogation of the G2 checkpoint was found to sensitize the
cells to an ionizing radiation and to lead to cell death [11].
In TRX-HT1080 cells, the cell distributions in the G0/G1, S
and G2/M phases were quite diﬀerent from that of the control
cells (Figs. 2A and 3B). Actually the fraction of the cells in G1
was highly increased (82.2%), which are known to be less sen-
sitive to an oxidative stress such as H2O2, while the fraction of
the S phase cells dramatically decreased (6.0%). This means
that the cell proliferation was signiﬁcantly suppressed because) The cell-cycle progression of c-irradiated cells (10 Gy) was analyzed
ion, whereas G2 phase transition of TRX-overexpressed HT-1080 cells
Fig. 3. The cell growth retardation and polyploidy of TRX-1-overexpressed cells. (A) The cell growth of TRX-1-overexpressed cells was measured by
Trypan Blue exclusion method. (B) The DNA contents of TRX-1-overexpressed cells were analyzed by ﬂow cytometry and the chromosomes were
visualized by Giemsa staining.
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addition, following the c-irradiation, the transition into the
G2 phase was signiﬁcantly abrogated in the TRX-HT1080 cells
(Fig. 2A and B). And, without the G2 phase transition, the
immediate cell death was appeared partly (Fig. 2A). Analysis
of the cell growth kinetics revealed that the TRX-HT1080 cells
to grow more slowly than the control cells (Fig. 3A). Surpris-
ingly, TRX-HT1080 cells were twofold or larger than the con-
trol as shown by Forward scatter/Side scatter analysis and
the DNA content was about twice as many as the control
(Fig. 3B). When the chromosomes of metaphase cells werevisualized with Giemsa staining, 84–92 chromosomes were
shown within one cell (Fig. 3B).
3.2. TRX-1 overexpression upregulated the expression of
senescence-related genes and induced an unbalancing of the
expression of cytoskeletal protein
G1 phase-arrest, polyploidy, and growth retardation are the
typical phenomena of cellular senescence [12]. To conﬁrm the
cellular senescence of TRX-HT1080 cells, two senescence
markers were measured, which are the senescence-b-galactosi-
dase activity [13] and the globular actin expression in the
Fig. 4. The detection of the cellular senescence markers in TRX-1-overexpressed cells. Globular actin staining and senescence b-galactosidase activity
staining were done for HT1080 cells and TRX-1-overexpressed cells. Actin expression was visualized with FITC-labeled antibody and senescence b-
galactosidase stained spots were shown as blue spots (indicated by arrow).
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showed blue-stained spots indicating b-galactosidase activity
and the actin accumulation in an enlarged nucleus, which
was not shown in the control cells. All of above data indicate
that overexpression of thioredoxin in HT-1080 cells induced a
global change of cellular state to a cellular senescence. To ana-
lyze the eﬀect of TRX-1 overexpression more precisely, we
investigated the total gene expression pattern by cDNA micro-
array studies. 517 genes out of the 8096 targets (6.4%) showed
a signiﬁcant diﬀerence in the gene expression (data not shown).
Among them, the genes, which are related to the redox regula-
tion, cell cycle regulation, and aging or polyploidy were com-
pared in Table 1. The mostly increased protein was
transgelin, about 10-fold higher than the control cells and itsTable 1
Relative gene expression ratio of TRX-overexpressed HT1080 cells
compared to control cells
Gene name Genbank#b Ratio of
mediansa
Transgelin AI668906 11.5593
Cyclin D1(PRAD1) AA487486 4.7835
Ran GTPase activating
protein 1
AA485734 4.2329
Cyclin D3 AI340905 3.9293
Tubulin, b5 N74524 3.8138
Tubulin, b, polypeptide AW081868 3.3845
Thioredoxin reductase 1 AA464849 3.2564
Tubulin, b2 AA888148 2.8761
Rho/rac guanine nucleotide
exchange factor
AA464578 2.4021
Glutathione peroxidase 1 AA485362 2.1223
Cyclin-dependent kinase inhibitor
1A (p21)
AI952615 2.0384
Actin, a2, smooth muscle AA634006 0.4453
Cyclin G1 AA082943 0.3955
Cyclin-dependent kinase 7 R22625 0.2972
Tubulin, a Tubulin,alpha 0.2111
Actin, b Actin, beta 0.1634
aFor ratio of medians, 8 or 0.2 means an 8-fold upregulation or a 5-
fold downregulation compared to control.
bInformation about gene function can be obtained by using GenBank#
in the table at http://genome-www5.stanford.edu/cgi-bin/SMD/source/
sourceSearch/.expression was conﬁrmed by Western blotting (Fig. 5A).
Transgelin is an actin binding protein and is known as another
senescence marker [15]. Other cytoskeleton proteins, such asFig. 5. The expression of trangelin and tubulin in TRX-1-overexpres-
sed cells. (A) Transgelin expression was detected by Western blotting.
10 lg of total cell lysates were separated on each lane. (B) Anti-tubulin
staining was done for G1- and M-phase cells.
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Ran, which are G proteins regulating the actin cytoskeleton
rearrangement, were also increased. On the other hand, the
expressions of tubulin-a, actin-a2, and actin-b were decreased
about 2–5-fold. The changes of the cytoskeleton protein
expression mean that the cellular framework was drastically
reorganized and the cell shape and movement would be very
diﬀerent from those of normal cells. The tubulin staining of
the TRX-HT1080 cells showed the typical phenomenon of a
polyploidic cell division (Fig. 5B). At the M-phase, the tubulin
staining showed a mitotic spindle array at the center of both
cells. Interestingly, the polyploidic cells showed two pairs of
mitotic spindle array.3.3. TRX-1-overexpressed polyploidy cells showed a
simultaneous stimulation of the mitogen-activated pathways
and an inhibition of the cyclin-dependent kinases
When a cellular senescence is induced, there are typical
expression patterns of the cell-cycle regulators [16]. In TRX-
HT1080 cells, the expressions of cyclin-dependent kinase 7
(CDK7) and cyclin G1 were decreased to 0.3–0.4-fold, whereas
the expressions of p21, p27, cyclin D1 and cyclin D3 were in-
creased 2–4-fold when compared by cDNA microarray (Table
1) or Western blotting (Fig. 6A). Cell-cycle analysis of the
TRX-HT1080 cells showed a signiﬁcantly reduced S-phase
and an increment of the G1 phase (Fig. 3B), which is accorded
with an increase of the cyclin-dependent kinase inhibitors
(CDKI; p21, p27). Activation of p21 is regulated by p53 [17],
of which an increment leads to an increment of p21. Another
regulator of p53, Cyclin G1, was decreased in TRX-HT1080
cells by 0.3-fold. Cyclin G1 is known to regulate p53 level neg-Fig. 6. Western blotting analysis of cell-cycle regulatory proteins in TRX-
inhibitors (p21 and p27) and cyclin D (D1 and D3) were analyzed by Weste
intracellular staining.atively [18]. In such a situation, p53 level might increase, and,
as expected, the expression of p53 increased by 3-fold in TRX-
HT1080 cells (Fig. 6B). p53 is also another typical protein
related to cellular senescence [19]. On the other hand, TRX-
HT1080 cells also showed an elevated level of cyclin D1 and
D3 (Table 1 and Fig. 6A). Unlike other cyclins, which ﬂuctuate
periodically during cell-cycle progression, the levels of D-cyc-
lins (cyclin D1, D2, and D3) are controlled by the extracellular
environments [20]. These cyclins are induced by a mitogenic
stimulation and their levels decline when the mitogens are
withdrawn. The elevated expression of cyclin D1 and D3 indi-
cates that the TRX-HT1080 cells should be exposed to extra-
cellular mitogenic stimuli, which may be caused by the
overexpressed TRX-1.4. Discussion
We report here that the TRX-overexpression in HT-1080
cells retarded the cell growth, induced polyploidy and cellu-
lar senescence and that these cells showed increment of cy-
clin D1, p53 and p21. The increment of cyclin D1 had
been reported in other cases of cellular senescence. Saegusa
et al. [21] reported that nuclear b-catenin simultaneously in-
duced the activation of the p53–p21 pathway and the over-
expression of cyclin D1 and these led to the suppression of
cell proliferation and cell senescence. Coco et al. [22] also
showed that the overexpression of cyclin D1 induced p53
and p21 in MCF-7 cells. And, as in our results, the cyclin
D1-overexpressed cells showed the increased radiation-in-
duced cell death. TRX-1-overexpressed HT-1080 cells
showed the upregulation of these cell-cycle regulators (cyclin1-overexpressed cells. (A) The expressions of cyclin-dependent kinase
rn blotting. (B) p53 levels were also analyzed by Western blotting and
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induced by thioredoxin overexpression seems to be the direct
cause of cellular senescence and increment of radiation-sen-
sitivity. For the cause of cellular senescence, several factors
have been proposed. And among them, the aging theory
caused by the accumulation of oxidative stress is the most
widely accepted [1] and there are several results supporting
this theory. When superoxide dismutase, catalase or thiore-
doxin [23–25], were introduced into fruitﬂies or mice their
life span were signiﬁcantly extened. The TRX-overexpressed
ﬁbrosarcoma cells of our studies showed an enhanced oxi-
dants scavenging ability. Therefore, from the view of oxi-
dant-induced senescence, cellular senescence of these cells
seems to be unusual. But in this case, the expression of cy-
clin D1 and other cell-cycle regulatory elements seems to be
a more important guide of cellular fate rather than the intra-
cellular oxidant level. In the further studies, it would be
necessary to analyze the relationship between the TRX-over-
expression and the upregulation of cyclin D1 of these cells.
Recently, Blagosklonny [16] proposed a cellular senescence
followed by a hypermitogenic arrest, which is caused by a
simultaneous stimulation of the mitogen-activated pathways
and a downstream inhibition of the cyclin-dependent kinases
(CDK). The hypermitogenic arrest was reported to be in-
duced when the anticancer drugs arrest cell growth, of which
the levels of cyclin D, E, A, or B were elevated [26,27] or
when phorbol esters, which inhibit CDK, were treated in
the presence of cyclin D1 [28]. The cellular senescence of
TRX-HT-1080 cells seems to be placed under the category
of this hypermitogenic arrest, which showed a simultaneous
elevated expression level of the cyclin D classes and p21 and
p27, which are CDK inhibitors and induce a G1 blockage.
Overproduction of human TRX in transgenic mice con-
ferred a resistance against various oxidative stresses [25].
An exogenous administration of human TRX also attenuated
a cell and tissue injury [29]. Therefore, the induction of endog-
enous TRX or gene therapy was proposed as an attractive
prescription for oxidative stress-associated disorders. Overex-
pressed TRX would function as an excellent oxidative stress
scavenger. But the other eﬀects of overexpressed TRX, such
as a cell growth regulator or gene expression regulator, would
be exhibited diﬀerently depending on the cell types as shown in
Section 3. And if overexpressed TRX induces a hypermito-
genic growth arrest and a genomic instability such as poly-
ploidy, which is critical factors of tumorigenesis, it could
increase the possibility of tumorigenesis. Then, the overexpres-
sion of thioredoxin would be not good for ones health or lon-
gevity but a start of another disease.
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